OTCMKTS:NXNN

Nexeon MedSystems Competitors

$0.55
0.00 (0.00 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.55
Now: $0.55
$0.55
50-Day Range
$0.20
MA: $0.37
$0.74
52-Week Range
$0.01
Now: $0.55
$1.25
VolumeN/A
Average Volume4,010 shs
Market Capitalization$1.12 million
P/E RatioN/A
Dividend YieldN/A
Beta12.71

Competitors

Nexeon MedSystems (OTCMKTS:NXNN) Vs. NIMU, RSLSD, MAGAA, ARDMQ, IMRSQ, and SCIE

Should you be buying NXNN stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Nexeon MedSystems, including Non-Invasive Monitoring Systems (NIMU), ReShape Lifesciences (RSLSD), Magna-Lab (MAGAA), Aradigm (ARDMQ), IMRIS (IMRSQ), and SpectraScience (SCIE).

Non-Invasive Monitoring Systems (OTCMKTS:NIMU) and Nexeon MedSystems (OTCMKTS:NXNN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.

Valuation and Earnings

This table compares Non-Invasive Monitoring Systems and Nexeon MedSystems' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Non-Invasive Monitoring SystemsN/AN/A$-160,000.00N/AN/A
Nexeon MedSystemsN/AN/AN/AN/AN/A

Profitability

This table compares Non-Invasive Monitoring Systems and Nexeon MedSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Non-Invasive Monitoring SystemsN/A-2,509.09%-80.19%
Nexeon MedSystemsN/AN/AN/A

Risk & Volatility

Non-Invasive Monitoring Systems has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500. Comparatively, Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Non-Invasive Monitoring Systems and Nexeon MedSystems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Non-Invasive Monitoring Systems0000N/A
Nexeon MedSystems0000N/A

Summary

Nexeon MedSystems beats Non-Invasive Monitoring Systems on 3 of the 3 factors compared between the two stocks.

ReShape Lifesciences (OTCMKTS:RSLSD) and Nexeon MedSystems (OTCMKTS:NXNN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Risk and Volatility

ReShape Lifesciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Comparatively, Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500.

Earnings & Valuation

This table compares ReShape Lifesciences and Nexeon MedSystems' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ReShape Lifesciences$610,000.000.00$-81,150,000.00N/AN/A
Nexeon MedSystemsN/AN/AN/AN/AN/A

Nexeon MedSystems has lower revenue, but higher earnings than ReShape Lifesciences.

Profitability

This table compares ReShape Lifesciences and Nexeon MedSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
ReShape Lifesciences-668.58%-163.22%-52.10%
Nexeon MedSystemsN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for ReShape Lifesciences and Nexeon MedSystems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
ReShape Lifesciences0000N/A
Nexeon MedSystems0000N/A

Summary

Nexeon MedSystems beats ReShape Lifesciences on 4 of the 5 factors compared between the two stocks.

Magna-Lab (OTCMKTS:MAGAA) and Nexeon MedSystems (OTCMKTS:NXNN) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Profitability

This table compares Magna-Lab and Nexeon MedSystems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Magna-LabN/A-12.32%42,399.99%
Nexeon MedSystemsN/AN/AN/A

Risk and Volatility

Magna-Lab has a beta of 5.2, indicating that its stock price is 420% more volatile than the S&P 500. Comparatively, Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings for Magna-Lab and Nexeon MedSystems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Magna-Lab0000N/A
Nexeon MedSystems0000N/A

Earnings & Valuation

This table compares Magna-Lab and Nexeon MedSystems' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Magna-LabN/AN/A$-130,000.00N/AN/A
Nexeon MedSystemsN/AN/AN/AN/AN/A

Summary

Nexeon MedSystems beats Magna-Lab on 2 of the 3 factors compared between the two stocks.

Nexeon MedSystems (OTCMKTS:NXNN) and Aradigm (OTCMKTS:ARDMQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Profitability

This table compares Nexeon MedSystems and Aradigm's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nexeon MedSystemsN/AN/AN/A
AradigmN/AN/AN/A

Risk and Volatility

Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500. Comparatively, Aradigm has a beta of 2.91, indicating that its stock price is 191% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Nexeon MedSystems and Aradigm, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nexeon MedSystems0000N/A
Aradigm0000N/A

Valuation and Earnings

This table compares Nexeon MedSystems and Aradigm's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexeon MedSystemsN/AN/AN/AN/AN/A
AradigmN/AN/AN/AN/AN/A

Summary

Nexeon MedSystems beats Aradigm on 1 of the 1 factors compared between the two stocks.

Nexeon MedSystems (OTCMKTS:NXNN) and IMRIS (OTCMKTS:IMRSQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Profitability

This table compares Nexeon MedSystems and IMRIS's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nexeon MedSystemsN/AN/AN/A
IMRISN/AN/AN/A

Risk and Volatility

Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500. Comparatively, IMRIS has a beta of -10.69, indicating that its stock price is 1,169% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Nexeon MedSystems and IMRIS, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nexeon MedSystems0000N/A
IMRIS0000N/A

Valuation and Earnings

This table compares Nexeon MedSystems and IMRIS's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexeon MedSystemsN/AN/AN/AN/AN/A
IMRISN/AN/AN/AN/AN/A

Summary

Nexeon MedSystems beats IMRIS on 1 of the 1 factors compared between the two stocks.

Nexeon MedSystems (OTCMKTS:NXNN) and SpectraScience (OTCMKTS:SCIE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Profitability

This table compares Nexeon MedSystems and SpectraScience's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Nexeon MedSystemsN/AN/AN/A
SpectraScienceN/AN/AN/A

Risk and Volatility

Nexeon MedSystems has a beta of 12.71, indicating that its stock price is 1,171% more volatile than the S&P 500. Comparatively, SpectraScience has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Nexeon MedSystems and SpectraScience, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Nexeon MedSystems0000N/A
SpectraScience0000N/A

Valuation and Earnings

This table compares Nexeon MedSystems and SpectraScience's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nexeon MedSystemsN/AN/AN/AN/AN/A
SpectraScienceN/AN/AN/AN/AN/A

Summary

Nexeon MedSystems beats SpectraScience on 1 of the 1 factors compared between the two stocks.


Nexeon MedSystems Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
NIMU
Non-Invasive Monitoring Systems
0.5$0.03flat$2.49 millionN/A0.00Upcoming Earnings
RSLSD
ReShape Lifesciences
0.4N/AN/A$1.94 million$610,000.000.00High Trading Volume
MAGAA
Magna-Lab
0.7$1.24flat$1.46 millionN/A6.89
ARDMQ
Aradigm
0.0$0.05flat$764,000.00N/A0.00
IMRIS logo
IMRSQ
IMRIS
0.5$0.01flat$468,000.00N/A0.00Gap Up
SCIE
SpectraScience
0.5$0.00flat$265,000.00N/A0.00
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.02flat$234,000.00N/A0.00Gap Down
ULGX
Urologix
0.6$0.01flat$111,000.00N/A0.00
AKSY
Aksys
0.0$0.05flat$0.00N/A0.00Gap Down
Escalon Medical logo
ESMC
Escalon Medical
0.5$0.39flat$0.00$9.40 million-6.50Gap Up
HRTT
Heart Tronics
0.0$0.02flat$0.00N/A0.00
IVVI
Ivivi Technologies
0.0$0.00flat$0.00N/A0.00High Trading Volume
NWCI
NewCardio
0.5$0.00flat$0.00N/A0.00Gap Up
PECN
Photoelectron
0.2$0.00flat$0.00N/A0.00
Trimedyne logo
TMED
Trimedyne
0.4$4.25flat$0.00$5.57 million0.00
XCRP
Xcorporeal
0.0$0.00flat$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.